Page last updated: 2024-09-05

lutein and c.i. 42510

lutein has been researched along with c.i. 42510 in 3 studies

Compound Research Comparison

Studies (lutein)	Trials (lutein)	Recent Studies (post-2010) (lutein)	Studies (c.i. 42510)	Trials (c.i. 42510)	Recent Studies (post-2010) (c.i. 42510)
2,770	267	1,422	4,960	190	1,366

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Badaro, E; Belfort, R; Furlani, B; Lima, AA; Lucatto, LF; Maia, M; Muccioli, C; Prazeres, J; Souza-Martins, D	1
Bee, YS; Chen, JL; Chen, YA; Lin, SH; Sheu, SJ; Shu, CW	1
Addo, EK; Bernstein, PS; Hartnett, ME	1

Trials

2 trial(s) available for lutein and c.i. 42510

Article	Year
Soluble lutein in combination with brilliant blue as a new dye for chromovitrectomy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2014, Volume: 252, Issue:7 Topics: Aged; Aged, 80 and over; Basement Membrane; Chromogenic Compounds; Drug Combinations; Endotamponade; Epiretinal Membrane; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Humans; Lutein; Male; Middle Aged; Prone Position; Prospective Studies; Retinal Perforations; Rosaniline Dyes; Surveys and Questionnaires; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Vitreous Body	2014
The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial. Trials, 2023, Jun-19, Volume: 24, Issue:1 Topics: Carotenoids; Clinical Trials, Phase II as Topic; Dietary Supplements; Genetic Testing; Humans; Lutein; Macular Degeneration; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Rosaniline Dyes; Zeaxanthins	2023

Article

Year

Soluble lutein in combination with brilliant blue as a new dye for chromovitrectomy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2014, Volume: 252, Issue:7

Topics: Aged; Aged, 80 and over; Basement Membrane; Chromogenic Compounds; Drug Combinations; Endotamponade; Epiretinal Membrane; Female; Fluorescein Angiography; Fluorocarbons; Follow-Up Studies; Humans; Lutein; Male; Middle Aged; Prone Position; Prospective Studies; Retinal Perforations; Rosaniline Dyes; Surveys and Questionnaires; Tomography, Optical Coherence; Visual Acuity; Vitrectomy; Vitreous Body

2014

The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial.

Trials, 2023, Jun-19, Volume: 24, Issue:1

Topics: Carotenoids; Clinical Trials, Phase II as Topic; Dietary Supplements; Genetic Testing; Humans; Lutein; Macular Degeneration; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Rosaniline Dyes; Zeaxanthins

2023

Other Studies

1 other study(ies) available for lutein and c.i. 42510

Article	Year
Differential autophagic effects of vital dyes in retinal pigment epithelial ARPE-19 and photoreceptor 661W cells. PloS one, 2017, Volume: 12, Issue:3 Topics: Animals; Autophagy; Cell Survival; Cells, Cultured; Chloroquine; Coloring Agents; Humans; Indocyanine Green; Lutein; Mice; Protective Agents; Resveratrol; Retinal Pigment Epithelium; Rosaniline Dyes; Stilbenes; Ubiquinone; Vitrectomy	2017